# Sino Biopharmaceutical Limited

> Chinese pharmaceutical company

**Wikidata**: [Q10874682](https://www.wikidata.org/wiki/Q10874682)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Sino_Biopharmaceutical_Limited)  
**Source**: https://4ort.xyz/entity/sino-biopharmaceutical-limited

## Summary

Sino Biopharmaceutical Limited is a Chinese pharmaceutical company listed on the Hong Kong Stock Exchange (stock code 1177) since December 8, 2003. It is a publicly traded company that develops, manufactures, and markets pharmaceutical products. The company is headquartered in Hong Kong and operates as a business entity engaged in the pharmaceutical industry.

## Key Facts

- **Legal Name:** Sino Biopharmaceutical Limited
- **Stock Exchange:** Hong Kong Stock Exchange
- **Stock Code:** 1177
- **IPO Date:** December 8, 2003
- **ISIN:** KYG8167W1380
- **Legal Entity Identifier:** 529900LPR4ADFEJAR786
- **Country:** Hong Kong
- **Website:** https://www.sinobiopharm.com/
- **Entity Type:** Business, public company
- **Wikipedia Title:** Sino Biopharmaceutical Limited
- **Wikipedia Languages:** English (en), Persian (fa), Russian (ru), Chinese (zh)
- **Google Knowledge Graph ID:** /g/155qfqgb
- **Wikidata Description:** Chinese pharmaceutical company
- **Sitelink Count:** 4

## FAQs

**What does Sino Biopharmaceutical Limited do?**

Sino Biopharmaceutical Limited is a Chinese pharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical products.

**Where is Sino Biopharmaceutical Limited listed?**

The company is listed on the Hong Kong Stock Exchange under the stock code 1177.

**When did Sino Biopharmaceutical Limited go public?**

Sino Biopharmaceutical Limited began trading on the Hong Kong Stock Exchange on December 8, 2003.

**What is the ISIN for Sino Biopharmaceutical Limited?**

The International Securities Identification Number (ISIN) for Sino Biopharmaceutical Limited is KYG8167W1380.

**What is the legal structure of Sino Biopharmaceutical Limited?**

Sino Biopharmaceutical Limited is a public company, meaning it offers its securities for sale to the general public and is traded on a public stock exchange.

**What languages does the Sino Biopharmaceutical Limited Wikipedia article exist in?**

The Wikipedia article for Sino Biopharmaceutical Limited is available in English, Persian, Russian, and Chinese.

## Why It Matters

Sino Biopharmaceutical Limited represents an important player in the Chinese pharmaceutical industry and the broader Asian healthcare sector. As a publicly traded company listed on the Hong Kong Stock Exchange since 2003, it provides investors with access to the growing Chinese pharmaceutical market. The company's public listing status means it adheres to regulatory disclosure and reporting standards, promoting transparency for investors and stakeholders. Its presence on one of Asia' major stock exchanges demonstrates its significance in the region's pharmaceutical landscape and its ability to attract international investment capital.

## Notable For

- Being listed on the Hong Kong Stock Exchange since 2003
- Operating as a publicly traded pharmaceutical company in China
- Having a presence across multiple language Wikipedia editions (English, Persian, Russian, Chinese)
- Holding a legal entity identifier for international business recognition
- Operating under ISIN KYG8167W1380 for securities identification

## Body

### Company Overview

Sino Biopharmaceutical Limited is a pharmaceutical company based in Hong Kong that operates within the Chinese pharmaceutical industry. The company is classified as a business and public company, meaning it offers its securities for sale to the general public through the Hong Kong Stock Exchange.

### Stock Exchange and Trading Information

The company is listed on the Hong Kong Stock Exchange, one of Asia' major financial markets. Trading commenced on December 8, 2003, under stock code 1177. The company' securities are identified by its ISIN number KYG8167W1380, which is used internationally for securities identification. Additionally, the company holds a Legal Entity Identifier (LEI) of 529900LPR4ADFEJAR786, which is used for financial transaction reporting purposes.

### Corporate Identity and Classification

Sino Biopharmaceutical Limited is classified as a business entity and specifically as a public company. This classification indicates that the company has completed an initial public offering (IPO) and allows its shares to be traded freely on the open market. The company is headquartered in Hong Kong, which serves as a major financial hub connecting Chinese companies with international investors.

### Digital Presence

The company maintains an official website at https://www.sinobiopharm.com/, providing information about its operations, products, and corporate activities. The company has a presence in the Google Knowledge Graph with identifier /g/155qfqgb, making it discoverable through Google' search features.

### Wikipedia and Reference Materials

Sino Biopharmaceutical Limited has Wikipedia articles in four language editions: English, Persian, Russian, and Chinese. This multilingual presence indicates the company' relevance across different regions and its recognition in international contexts. The company' Wikidata description identifies it simply as a "Chinese pharmaceutical company," reflecting its primary business focus.

### Regulatory and Financial Identification

As a public company, Sino Biopharmaceutical Limited operates under regulatory oversight that requires transparency in financial reporting and corporate governance. The company' various identification codes (ISIN, LEI, stock code) facilitate its identification in international financial markets, trading systems, and regulatory filings.

## References

1. Global LEI Index